{"id":48129,"date":"2022-09-08T18:02:07","date_gmt":"2022-09-08T16:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/"},"modified":"2022-09-08T18:02:07","modified_gmt":"2022-09-08T16:02:07","slug":"maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/","title":{"rendered":"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September"},"content":{"rendered":"<div>\n<p>LYON, France&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24MAAT&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$MAAT<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.maatpharma.com%2F&amp;esheet=52876540&amp;newsitemid=20220908005767&amp;lan=en-US&amp;anchor=MaaT+Pharma&amp;index=1&amp;md5=a238759e9bb4303e03707383f7a4c641\" rel=\"nofollow noopener\" shape=\"rect\">MaaT Pharma<\/a> <b>(EURONEXT: MAAT \u2013 the \u201cCompany\u201d), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem Therapies<sup>TM<\/sup> (MET) dedicated to improving survival outcomes for patients with cancer<\/b>, today announced that Herv\u00e9 Affagard, CEO and co-founder of MaaT Pharma, and Si\u00e2n Crouzet, CFO of MaaT Pharma, will participate in three upcoming investor conferences.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/5\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\"><\/a><\/p>\n<p>\nDetails for the events are as follow:\n<\/p>\n<p>\n<b>H.C. Wainwright 24th Annual Global Investment Conference (hybrid format)<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Format:<\/i> virtual presentation &amp; investor meetings\n<\/li>\n<li>\n<i>Presentation date:<\/i> Herv\u00e9 Affagard will present the Company and provide a corporate update.\n<\/li>\n<\/ul>\n<p>\nThe presentation will be available <b>on-demand<\/b> through the H.C. Wainwright conference portal, starting at 7:00 am EST\/1:00 pm CET on <b>Monday, September 12, 2022<\/b>. A replay will be available on the investor page of Maat Pharma\u2019s website: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.maatpharma.com%2Finvestors%2F&amp;esheet=52876540&amp;newsitemid=20220908005767&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.maatpharma.com%2Finvestors%2F&amp;index=2&amp;md5=e67d8da0c8c983212037bb120a383b99\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.maatpharma.com\/investors\/<\/a>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Link:<\/i> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhcwevents.com%2Fglobalconference%2F%23toggle-id-4&amp;esheet=52876540&amp;newsitemid=20220908005767&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhcwevents.com%2Fglobalconference%2F%23toggle-id-4&amp;index=3&amp;md5=3d841b2ec8eccc7147e30fdb079f360f\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/hcwevents.com\/globalconference\/#toggle-id-4<\/a>\n<\/li>\n<\/ul>\n<p>\n<b>KBC Securities Life Sciences conference (virtual)<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Format:<\/i> virtual investor meetings\n<\/li>\n<li>\n<i>Date:<\/i> <b>Thursday,<\/b> <b>September 15<\/b><b> and Friday, September 16, 2022<\/b>\n<\/li>\n<\/ul>\n<p>\n<b>5th edition of the <i>\u201cFORUM Lyon P\u00f4le Bourse Valeurs R\u00e9gionales\u201d<\/i> (on-site event)<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Format:<\/i> investor meetings\n<\/li>\n<li>\n<i>Date:<\/i> <b>Wednesday, September 28, 2022<\/b>\n<\/li>\n<li>\n<i>Location:<\/i> Lyon, France\n<\/li>\n<li>\n<i>Link: <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fforum.lyonpolebourse.com%2Fform.aspx&amp;esheet=52876540&amp;newsitemid=20220908005767&amp;lan=en-US&amp;anchor=https%3A%2F%2Fforum.lyonpolebourse.com%2Fform.aspx&amp;index=4&amp;md5=9328cf38eeb8d65e16509b97a62e5866\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/forum.lyonpolebourse.com\/form.aspx<\/a>\n<\/li>\n<\/ul>\n<p>\n<b>About MaaT Pharma<\/b>\n<\/p>\n<p>\nMaaT Pharma, a clinical stage biotechnology company, has established a complete approach to restoring patient-microbiome symbiosis in oncology. Committed to treating cancer and graft-versus-host disease (GvHD), a serious complication of allogeneic stem cell transplantation, MaaT Pharma launched in March 2022 in Europe, a Phase 3 clinical trial for patients with acute GvHD, following the achievement of its proof of concept in a Phase 2 trial. Its powerful discovery and analysis platform, gutPrint\u00ae, supports the development and expansion of its pipeline by determining novel disease targets, evaluating drug candidates, and identifying biomarkers for microbiome-related conditions. The company\u2019s Microbiome Ecosystem Therapies are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome, in liquid and oral formulations. MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to support the integration of the use of microbiome therapies in clinical practice.\n<\/p>\n<p>\nMaaT Pharma is the first company developing microbiome-based therapies listed on Euronext Paris (ticker: MAAT).\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>MaaT Pharma \u2013 Investor Relations<\/b><br \/>Herv\u00e9 AFFAGARD<br \/>\n<br \/>Co-Founder and CEO<br \/>\n<br \/>Si\u00e2n Crouzet, COO\/ CFO<br \/>\n<br \/>+33 4 28 29 14 00<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#105;&#x6e;&#x76;&#101;&#x73;&#x74;&#64;&#109;&#x61;a&#116;&#x2d;&#x70;&#104;&#x61;&#x72;m&#97;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x6e;&#x76;e&#115;&#x74;&#64;&#109;&#x61;&#x61;&#116;&#x2d;&#x70;h&#97;&#x72;m&#97;&#x2e;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<p>\n<b>MaaT Pharma \u2013 Media Relations<\/b><br \/>Pauline RICHAUD<br \/>\n<br \/>Senior PR &amp; Corporate Communications Manager<br \/>\n<br \/>+33 6 07 55 25 36<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;o:&#112;&#114;&#x69;&#x63;ha&#117;&#100;&#x40;&#x6d;aa&#116;&#x2d;&#x70;&#x68;a&#114;&#109;&#x61;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x69;&#x63;&#x68;a&#117;&#x64;&#x40;&#x6d;a&#97;&#x74;&#x2d;&#x70;h&#97;&#x72;&#x6d;&#x61;&#46;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Trophic Communications \u2013 Corporate and Medical Communications<\/b><br \/>Jacob VERGHESE or<br \/>\n<br \/>Gretchen SCHWEITZER<br \/>\n<br \/>+49 89 2070 89831<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;o:&#x6d;&#x61;&#x61;&#116;&#64;tr&#x6f;&#x70;&#x68;&#105;&#99;&#46;e&#x75;\" rel=\"nofollow noopener\" shape=\"rect\">maa&#116;&#64;&#116;&#x72;&#x6f;&#x70;&#x68;&#x69;&#x63;&#46;eu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LYON, France&#8211;(BUSINESS WIRE)&#8211;$MAAT&#8212;MaaT Pharma (EURONEXT: MAAT \u2013 the \u201cCompany\u201d), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced that Herv\u00e9 Affagard, CEO and co-founder of MaaT Pharma, and Si\u00e2n Crouzet, CFO of MaaT Pharma, will participate in three &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48129","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LYON, France&#8211;(BUSINESS WIRE)&#8211;$MAAT&#8212;MaaT Pharma (EURONEXT: MAAT \u2013 the \u201cCompany\u201d), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced that Herv\u00e9 Affagard, CEO and co-founder of MaaT Pharma, and Si\u00e2n Crouzet, CFO of MaaT Pharma, will participate in three ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T16:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September\",\"datePublished\":\"2022-09-08T16:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/\"},\"wordCount\":415,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005767\\\/en\\\/729326\\\/21\\\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/\",\"name\":\"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005767\\\/en\\\/729326\\\/21\\\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\",\"datePublished\":\"2022-09-08T16:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005767\\\/en\\\/729326\\\/21\\\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005767\\\/en\\\/729326\\\/21\\\/Nov_2018_new_version_MaaT_Pharma_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September - Pharma Trend","og_description":"LYON, France&#8211;(BUSINESS WIRE)&#8211;$MAAT&#8212;MaaT Pharma (EURONEXT: MAAT \u2013 the \u201cCompany\u201d), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced that Herv\u00e9 Affagard, CEO and co-founder of MaaT Pharma, and Si\u00e2n Crouzet, CFO of MaaT Pharma, will participate in three ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-08T16:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September","datePublished":"2022-09-08T16:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/"},"wordCount":415,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/","url":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/","name":"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg","datePublished":"2022-09-08T16:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005767\/en\/729326\/21\/Nov_2018_new_version_MaaT_Pharma_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/maat-pharma-announces-participation-in-three-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48129"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48129\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}